Biosimilars
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Mylan
PR-M10-18-NI-071Oct 22, 2018
Biosimilar
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Mylan
PR-M09-18-NI-087Sep 27, 2018
Biosimilars
Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived
Kalorama Information
PR-M01-18-NI-086Jan 26, 2018
Biosimilars
First Biosimilar to Treat Breast and Stomach Cancers Approved
Nice Insight
PAO-M12-17-NI-007Dec 07, 2017
Biosimilar
FDA Recommends Approval of Trastuzumab Biosimilar
Guy Tiene
Nice Insight
PAO-M07-17-NI-025Jul 21, 2017